Simultaneous Impact of Atorvastatin and Mesenchymal Stem Cells for Glioblastoma Multiform Suppression in Rat Glioblastoma Multiform Model Publisher Pubmed



Goodarzi A¹ ; Khanmohammadi M² ; Ai A³ ; Khodayari H^{4, 5, 7} ; Ai A³ ; Farahani MS^{4, 5, 7} ; Khodayari S^{4, 5, 7} ; Ebrahimibarough S⁸ ; Mohandesnezhad S⁸ ; Ai J⁸ Show Affiliations
Source: Molecular Biology Reports Published:2020

Abstract

Glioblastoma multiform (GBM) is known as an aggressive glial neoplasm. Recently incorporation of mesenchymal stem cells with anti-tumor drugs have been used due to lack of immunological responses and their easy accessibility. In this study, we have investigated the anti-proliferative and apoptotic activity of atorvastatin (Ator) in combination of mesenchymal stem cells (MSCs) on GBM cells in vitro and in vivo. The MSCs isolated from rats and characterized for their multi-potency features. The anti-proliferative and migration inhibition of Ator and MSCs were evaluated by MTT and scratch migration assays. The annexin/PI percentage and cell cycle arrest of treated C6 cells were evaluated until 72 h incubation. The animal model was established via injection of C6 cells in the brain of rats and subsequent injection of Ator each 3 days and single injection of MSCs until 12 days. The growth rate, migrational phenotype and cell cycle progression of C6 cells decreased and inhibited by the interplay of different factors in the presence of Ator and MSCs. The effect of Ator and MSCs on animal models displayed a significant reduction in tumor size and weight. Furthermore, histopathology evaluation proved low hypercellularity and mitosis index as well as mild invasive tumor cells for perivascular cuffing without pseudopalisading necrosis and small delicate vessels in Ator + MSCs condition. In summary, Ator and MSCs delivery to GBM model provides an effective strategy for targeted therapy of brain tumor. © 2020, The Author(s).